Osiris Therapeutics, Inc. (NASDAQ:OSIR)
CAPS Rating:
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
Recs
Burning cash like a rocket burning fuel at takeoff, Osiris is developing unique and much needed products. It may be several years before this stock takes off in the direction of ISRG but if they are successful in product development the potential is here. I believe adult stem cell research and development is the only ethical stem cell path and have put my money where my heart is!